SYNERGISTIC EFFECT OF NISOLDIPINE AND NITROGLYCERIN ON HUMAN INTERNALMAMMARY ARTERY

Citation
Jj. Liu et al., SYNERGISTIC EFFECT OF NISOLDIPINE AND NITROGLYCERIN ON HUMAN INTERNALMAMMARY ARTERY, The Journal of pharmacology and experimental therapeutics, 268(1), 1994, pp. 434-440
Citations number
23
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00223565
Volume
268
Issue
1
Year of publication
1994
Pages
434 - 440
Database
ISI
SICI code
0022-3565(1994)268:1<434:SEONAN>2.0.ZU;2-M
Abstract
Perioperative spasm of the internal mammary artery (IMA) can be a prob lem in coronary artery bypass surgery, which may be prevented by vasod ilator drugs. The relaxing effect of a new calcium antagonist nisoldip ine used alone or in combination with nitroglycerin (NTG) was studied in human isolated IMA in organ chambers. The results showed that nisol dipine exhibited a potent relaxing effect on IMA precontracted by memb rane depolarization (K+ induced) with an EC(50) Of 7.58 +/- 0.08 (-log M). Nisoldipine was about 10 times more potent than was nifedipine (E C(50), 6.72 +/- 0.10). However, both calcium antagonists showed much l ess relaxing effect on IMA precontracted with the thromboxane mimetic U46619. When IMA was pretreated with nisoldipine, this drug (range, 10 -300 nM) inhibited contraction induced by either K+ or U46619 in a con centration-dependent manner. The relaxing effect of nisoldipine was lo ng lasting and extremely hard to wash out (more than 3 hr). NTG showed a rapid and short-lasting relaxing effect on IMA precontracted with e ither K+ or U46619. Pretreatment of IMA with NTG had little effect for prevention of contraction to K+ or U46619. Combining nisoldipine with NTG at low concentrations (1-30 nM) produced a synergistic effect in the prevention of IMA contraction to K+ or U46619 and in relaxation of IMA precontracted with these agents. These studies reveal that combin ing nisoldipine with NTG combines the advantages of both and provide a scientific basis for a future clinical trial using combined nisoldipi ne and NTG at low concentrations for the preparation of IMA (pretreatm ent) to prevent IMA spasm during coronary artery bypass grafting.